Key result
The dipyridamole test induced electrocardiographic signs of ischemia in 74% of patients with angina on effort, but was negative in all patients with angina at rest and control subjects.
Why the study?
Does the dipyridamole test accurately diagnose angina pectoris by inducing electrocardiographic signs of ischemia?
Cross-Sectional (n=66)
Does the dipyridamole test accurately diagnose angina pectoris by inducing electrocardiographic signs of ischemia?
The intravenous dipyridamole test has high specificity but lower sensitivity than exercise testing for diagnosing angina pectoris, likely inducing ischemia via flow maldistribution.
Answers are grounded in this paper and cite their sources.
May support dipyridamole ECG testing for effort angina with high specificity; leaves open prospective validation versus exercise testing.
The value of the dipyridamole test (0.75 mg/kg i.v.) in the diagnosis of angina pectoris was studied in 54 patients with angina pectoris (35 with angina on effort associated or not associated with rest angina and 19 with angina only at rest) and in 12 control subjects. The test induced electrocardiographic signs of ischemia (positive test) in 74% of patients with angina on effort, while it was negative in all cases with angina only at rest and in control subjects. All anginal patients with normal coronary arteries or less than 50% stenosis had a negative test; a positive response was observed in 36, 79 and 60% of cases with one-, two-or three-vessel disease, respectively. Hemodynamic changes with a marked arteriolar vasodilatation were observed both in the negative and in the positive tests. In the positive tests no significant change of double product, blood pressure and left ventricular end-diastolic pressure occurred before ischemia appeared. The results of the study show that dipyridamole as a diagnostic test in angina pectoris has a high specificity but a lower sensitivity than exercise test. The hemodynamic and eletrocardiographic findings in the positive tests suggest that dipyridamole-induced ischemia is due to a flow maldistribution with selective subendocardial ischemia secondary to the coronary arteriolar dilatation caused by the drug.
No takes yet. Share an insight, caveat, or question.
Tavazzi et al. (2008) conducted a cross-sectional in Angina pectoris (n=66). Dipyridamole test vs. Control subjects and patients with angina only at rest was evaluated on Electrocardiographic signs of ischemia (positive test). The dipyridamole test induced electrocardiographic signs of ischemia in 74% of patients with angina on effort, but was negative in all patients with angina at rest and control subjects.
Synapse has enriched 10 related papers. Consider them for comparative context: